Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report
暂无分享,去创建一个
Sung Sook Lee | F. Shepherd | Dong-Wan Kim | G. Chang | J. Yang | J. S. Lee | L. Horn | Gyeong-Won Lee | Yun-Gyoo Lee | Yu-Feng Wei | G. Laus | B. Collins | F. Pisetzky | S. S. Lee | J. Lee